错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Short-term outcomes of a multicentre prospective study using a “visible” polyvinylidene fluoride onlay mesh for the prevention of midline incisional hernia

  • José Luis Rodicio Miravalles,
  • Carlos San Miguel Méndez,
  • Javier Lopez-Monclus,
  • María Moreno Gijón,
  • Patricia López Quindós,
  • Sonia Amoza Pais,
  • Antonio López López,
  • Isabel García Bear,
  • Rafael Menendez de Llano Ortega,
  • María Isabel Díez Pérez de las Vacas,
  • Miguel Angel Garcia-Urena

摘要

Introduction

Prophylactic meshes in high-risk patients prevent incisional hernias, although there are still some concerns about the best layer to place them in, the type of fixation, the mesh material, the significance of the level of contamination, and surgical complications. We aimed to provide answers to these questions and information about how the implanted material behaves based on its visibility under magnetic resonance imaging (MRI).

Method

This is a prospective multicentre observational cohort study. Preliminary results from the first 3 months are presented. We included general surgical patients who had at least two risk factors for developing an incisional hernia. Multivariate logistic regression was used. A polyvinylidene fluoride (PVDF) mesh loaded with iron particles was used in an onlay position. MRIs were performed 6 weeks after treatment.

Results

Between July 2016 and June 2022, 185 patients were enrolled in the study. Surgery was emergent in 30.3% of cases, contaminated in 10.7% and dirty in 11.8%. A total of 5.6% of cases had postoperative wound infections, with the requirement of stoma being the only significant risk factor (OR = 7.59, p = 0.03). The formation of a seroma at 6 weeks detected by MRI, was associated with body mass index (OR = 1.13, p = 0.02).

Conclusions

The prophylactic use of onlay PVDF mesh in midline laparotomies in high-risk patients was safe and effective in the short term, regardless of the type of surgery or the level of contamination. MRI allowed us to detect asymptomatic seromas during the early process of integration.

Study registration: This protocol was registered at ClinicalTrials.gov (NCT03105895).